For Meningitis B Vaccines, Climbing Revenue, and Plenty of Skepticism – The New York Times

Read article - Quotes Adrienne Faerber, lecturer at the Dartmouth Institute for Health Policy and Clinical Practice, about the costs of the meningitis B vaccine. "Parents believe their children are susceptible to this terrible condition, and [drugmakers] use that fear to get parents to take action," says Faerber.